Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

BASF selects dual D4/5-HT2 antagonist for clinical development

April 22, 1997

MS&D designs potent and selective dopamine D4 antagonist

April 21, 1997

New opioid analgesic from Glaxo Wellcome

April 21, 1997

U.K. approval for Edronax

April 21, 1997

Imitrex Nasal Spray introduced in Canada

April 21, 1997

Warner-Lambert describes new dopamine D4 antagonists

April 18, 1997

Synergistic benefit of citicoline and NMDA antagonist shown in animal models of stroke

April 18, 1997

BASF describes new glutamate antagonists

April 18, 1997

Naropin introduced in Germany

April 18, 1997

Aricept launched in U.K.

April 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...